Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice

Journal of Controlled Release(2025)10.1016/j.jconrel.2025.113902Source: DataRank Database

COG133 peptide-conjugated lipid nanoparticles sensitize medulloblastoma to radiation therapy in mice is a research paper published in Journal of Controlled Release (2025). On theSindex it has a DataRank of 0.292. It has been cited 6 times.

N/A

0.292DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 1.87)OA: greenTopics (53)IDs (PubMed, OpenAlex)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.292

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (5)

Sohan Mahto ORCID,Rebecca E Deegan,Donald W. Coulter ORCID,Ram I. Mahato ORCID,Aditya K. Gupta ORCID

Live enrichment

PubMed:40449803 OpenAlex:https://openalex.org/W4410845625

Children's Hospital of Philadelphia

Grant: LB805

National Institutes of Health

Grant: 1R01NS128336

National Institutes of Health

Grant: 1R01NS116037

NINDS NIH HHS

Grant: R01 NS116037

NINDS NIH HHS

Grant: R01 NS128336

University of Nebraska Medical Center

FWCI

1.87

Citation Percentile

0.8%

Citation Trend

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12794628/

publisherhttps://api.elsevier.com/content/article/PII:S016836592500522X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S016836592500522X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jconrel.2025.113902

Fields of Study

Nanoplatforms for cancer theranosticsRNA Interference and Gene DeliveryNanoparticle-Based Drug DeliveryAnimalsNanoparticlesMedulloblastomaCell Line, TumorHumansPteridinesCerebellar NeoplasmsLipidsMicePolo-Like Kinase 1Radiation-Sensitizing AgentsCell Cycle ProteinsProto-Oncogene ProteinsProtein Serine-Threonine KinasesMice, NudeFemaleLiposomes

MeSH Terms

Polo-Like Kinase 1AnimalsCerebellar NeoplasmsFemaleHumansLipidsLiposomesMedulloblastomaMice, NudeProto-Oncogene ProteinsPteridinesRadiation-Sensitizing AgentsProtein Serine-Threonine KinasesCell Cycle ProteinsCell Line, TumorMiceNanoparticles

Keywords

MedulloblastomaPeptideConjugated systemRadiation therapyNanoparticleCancer researchChemistryMedicineInternal medicineNanotechnologyBiochemistryMaterials sciencePlk1 InhibitorLipid NanoparticlesVolasertibApoe Mimetic Peptide